Nanoscience research, which involves molecules only one one-hundreth the size of cancer cells, is on path to profoundly improve health and medical treatments in the coming decade, according to nine ...
AI as defined by the UK Intellectual Property Office (‘UK IPO’) and European Patent Office (‘EPO’) Applications of AI in biotechnology How biotechnology companies can leverage AI to drive innovation ...
Luxa Biotechnology Announces Publication in Cell Stem Cell Describing Positive Clinical Results for First-in-Human Clinical Trial for Dry AMD Therapy Luxa Biotechnology LLC (Luxa), a clinical-stage ...
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that it has entered into an exclusive worldwide license agreement with Sanofi for three clinical-stage masked ...
Vir Biotechnology (VIR) is presenting initial Phase 1 data from two of its dual-masked T-cell engagers: VIR-5818, targeting a variety of HER2-expressing solid tumors; and VIR-5500, targeting PSMA in ...
Sana Biotechnology reports six-month results from a first-in-human study demonstrating safe pancreatic islet cell transplantation for type 1 diabetes without immunosuppression. Sana Biotechnology ...
Article ‘Count’ and ‘Share’ for Institute of Nanoscience and Nanotechnology (IN) based on listed parameters only. According to the parameters selected above, there are no articles from Institute of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback